Acyl-CoA synthetase long-chain family member 6 is associated with premature ovarian failure

Fertility and Sterility

Volumn 91, Issue 4 SUPPL., 2009, Pages 1339-1343

  Kang, HyunJun ^a   Lee, Seung Ku ^a   Kim, Min Ho ^a   Choi, HyeJeong ^a   Lee, Sook Hwan ^a,b   Kwack, KyuBum ^a  

^a CHA University   (South Korea)

^b Ministry of Health and Welfare   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ARACHIDONOYL COENZYME A; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE;

ACYLATION; ARTICLE; CHROMOSOME 5Q; FATTY ACID METABOLISM; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GRANULOSA CELL; HAPLOTYPE; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 5; COENZYME A LIGASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; OVARIAN FAILURE, PREMATURE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 63249121487     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.03.035     Document Type: Article

References (63)

1. Coulam C.B. Premature gonadal failure. Fertil Steril 38 (1982) 645-655
2. Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol (Paris) 64 (2003) 87-92
3. Hoek A., Schoemaker J., and Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 18 (1997) 107-134
4. Meirow D., and Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 7 (2001) 535-543
5. Guerrero N.V., Singh R.H., Manatunga A., Berry G.T., and Steiner R.D. Elsas LJ II. Risk factors for premature ovarian failure in females with galactosemia. J Pediatr 137 (2000) 833-841
6. Tibiletti M.G., Testa G., Vegetti W., Alagna F., Taborelli M., Dalprà L., et al. The idiopathic forms of premature menopause and early menopause show the same genetic pattern. Hum Reprod 14 (1999) 2731-2734
7. Wise P.M., Krajnak K.M., and Kashon M.L. Menopause: the aging of multiple pacemakers. Science 273 (1996) 67-70
8. Osei-Hyiaman D., Satoshi T., Ueji M., Hideto T., and Kano K. Timing of menopause, reproductive years, and bone mineral density: a cross-sectional study of postmenopausal Japanese women. Am J Epidemiol 148 (1998) 1055-1061
9. Luborsky J.L., Meyer P., Sowers M.F., Gold E.B., and Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 8 (2003) 199-206
10. Chang S.H., Kim C.S., Lee K.S., Kim H., Yim S.V., Lim Y.J., et al. Premenopausal factors influencing premature ovarian failure and early menopause. Maturitas 58 (2007) 19-30
11. Vegetti W., Grazia Tibiletti M., Testa G., de Lauretis Y., Alagna F., Castoldi E., et al. Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum Reprod 13 (1998) 1796-1800
12. Conway G.S. Premature ovarian failure. Curr Opin Obstet Gynecol 9 (1997) 202-206
13. Woad K.J., Watkins W.J., Prendergast D., and Shelling A.N. The genetic basis of premature ovarian failure. Aust N Z J Obstet Gynaecol 46 (2006) 242-244
14. Mattison D.R., Evans M.I., Schwimmer W.B., White B.J., Jensen B., and Schulman J.D. Familial premature ovarian failure. Am J Hum Genet 36 (1984) 1341-1348
15. Holland C.M. 47,XXX in an adolescent with premature ovarian failure and autoimmune disease. J Pediatr Adolesc Gynecol 14 (2001) 77-80
16. Conway G.S., Hettiarachchi S., Murray A., and Jacobs P.A. Fragile X permutations in familial premature ovarian failure. Lancet 346 (1995) 309-310
17. Zinn A.R. The X chromosome and the ovary. J Soc Gynecol Investig 8 (2001) S34-S36
18. Aittomaki K., Lucena J.L., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82 (1995) 959-968
19. Harris S.E., Chand A.L., Winship I.M., Gersak K., Nishi Y., Yanase T., et al. INHA promoter polymorphisms are associated with premature ovarian failure. Mol Hum Reprod 11 (2005) 779-784
20. Conway G.S., Conway E., Walker C., Hoppner W., Gromoll J., and Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf) 51 (1999) 97-99
21. Jeong H.J., Cho S.W., Kim H.A., Lee S.H., Cho J.H., Choi D.H., et al. G769A variation of inhibin alpha-gene in Korean women with premature ovarian failure. Yonsei Med J 45 (2004) 479-482
22. Burchard E.G., Ziv E., Coyle N., Gomez S.L., Tang H., Karter A.J., et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 348 (2003) 1170-1175
23. Phimister E.G. Medicine and the racial divide. N Engl J Med 348 (2003) 1081-1082
24. Jones R., Pembrey M., Golding J., and Herrick D. The search for genotype/phenotype associations and the phenome scan. Paediatr Perinat Epidemiol 19 (2005) 264-275
25. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 (2005) 95-108
26. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22 (1999) 139-144
27. Cheung V.G., Spielman R.S., Ewens K.G., Weber T.M., Morley M., and Burdick J.T. Mapping determinants of human gene expression by regional and genome-wide association. Nature 437 (2005) 1365-1369
28. Gunderson K.L., Kruglyak S., Graige M.S., Garcia F., Kermani B.G., Zhao C., et al. Decoding randomly ordered DNA arrays. Genome Res 14 (2004) 870-877
29. Gunderson K.L., Steemers F.J., Lee G., Mendoza L.G., and Chee M.S. A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 37 (2005) 549-554
30. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
31. Devlin B., and Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29 (1995) 311-322
32. Qin Z.S., Niu T., and Liu J.S. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 71 (2002) 1242-1247
33. Risch N.J. Searching for genetic determinants in the new millennium. Nature 405 (2000) 847-856
34. Coleman R.A., Lewin T.M., Van Horn C.G., and Gonzalez-Baro M.R. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways?. J Nutr 132 (2002) 2123-2126
35. Hisanaga Y., Ago H., Nakagawa N., Hamada K., Ida K., Yamamoto M., et al. Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer. J Biol Chem 279 (2004) 31717-31726
36. Lands W.E. Stories about acyl chains. Biochim Biophys Acta 1483 (2000) 1-14
37. Malhotra K.T., Malhotra K., Lubin B.H., and Kuypers F.A. Identification and molecular characterization of acyl-CoA synthetase in human erythrocytes and erythroid precursors. Biochem J 344 (1999) 135-143
38. Iijima H., Fujino T., Minekura H., Suzuki H., Kang M.J., and Yamamoto T. Biochemical studies of two rat acyl-CoA synthetases, ACS1 and ACS2. Eur J Biochem 242 (1996) 186-190
39. Kang M.J., Fujino T., Sasano H., Minekura H., Yabuki N., Nagura H., et al. A novel arachidonate-preferring acyl-CoA synthetase is present in steroidogenic cells of the rat adrenal, ovary, and testis. Proc Natl Acad Sci U S A 94 (1997) 2880-2884
40. Marszalek J.R., Kitidis C., Dararutana A., and Lodish H.F. Acyl-CoA synthetase 2 overexpression enhances fatty acid internalization and neurite outgrowth. J Biol Chem 279 (2004) 23882-23891
41. Oikawa E., Iijima H., Suzuki T., Sasano H., Sato H., Kamataki A., et al. A novel acyl-CoA synthetase, ACS5, expressed in intestinal epithelial cells and proliferating preadipocytes. J Biochem 124 (1998) 679-685
42. Mu Y.M., Yanase T., Nishi Y., Tanaka A., Saito M., Jin C.H., et al. Saturated FFAs, palmitic acid and stearic acid, induce apoptosis in human granulosa cells. Endocrinology 142 (2001) 3590-3597
43. Marszalek J.R., Kitidis C., Dirusso C.C., and Lodish H.F. Long-chain acyl-CoA synthetase 6 preferentially promotes DHA metabolism. J Biol Chem 280 (2005) 10817-10826
44. Tang D.G., Guan K.L., Li L., Honn K.V., Chen Y.Q., Rice R.L., et al. Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. Int J Cancer 72 (1997) 1078-1087
45. Fujimoto Y., Tsunomori M., Sumiya T., Nishida H., Sakuma S., and Fujita T. Effects of fatty acyl coenzyme A esters on lipoxygenase and cyclooxygenase metabolism of arachidonic acid in rabbit platelets. Prostaglandins Leukot Essent Fatty Acids 52 (1995) 255-258
46. Fuse I., Iwanaga T., and Tai H.H. Phorbol ester, 1,2-diacylglycerol, and collagen induce inhibition of arachidonic acid incorporation into phospholipids in human platelets. J Biol Chem 264 (1989) 3890-3895
47. Oh-ishi S., Yamaki K., Abe M., Tomoda H., and Omura S. The acyl-CoA synthetase inhibitor triacsin C enhanced eicosanoid release in leukocytes. Jpn J Pharmacol 59 (1992) 417-418
48. Kudo I., and Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 68-69 (2002) 3-58
49. Urade Y., Watanabe K., and Hayaishi O. Prostaglandin D, E, and F synthases. J Lipid Mediat Cell Signal 12 (1995) 257-273
50. Vane J.R., and Botting R.M. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47 Suppl 2 (1998) S78-S87
51. Borgeat P. Biochemistry of the lipoxygenase pathways in neutrophils. Can J Physiol Pharmacol 67 (1989) 936-942
52. Homaidan F.R., Chakroun I., Haidar H.A., and El-Sabban M.E. Protein regulators of eicosanoid synthesis: role in inflammation. Curr Protein Pept Sci 3 (2002) 467-484
53. Samuelsson B., Dahlen S.E., Lindgren J.A., Rouzer C.A., and Serhan C.N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237 (1987) 1171-1176
54. Lewis R.A., Austen K.F., and Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. New Engl J Med 323 (1990) 645-655
55. Ford-Hutchinson A.W., Bray M.A., Doig M.V., Shipley M.E., Smith M.J., and Leukotriene B. a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286 (1980) 264-265
56. Serhan C.N., and Prescott S.M. The scent of a phagocyte: advances on leukotriene B4 receptors. J Exp Med 192 (2000) F5-F8
57. Huang W.W., Garcia-Zepeda E.A., Sauty A., Oettgen H.C., Rothenberg M.E., and Luster A.D. Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils. J Exp Med 188 (1998) 1063-1074
58. Tager A.M., and Luster A.D. BLT1 and BLT2: the leukotriene B (4) receptors. Prostaglandins Leukot Essent Fatty Acids 69 (2003) 123-134
59. Hoek A., van Kasteren Y., de Haan-Meulman M., Hooijkaas H., Schoemaker J., and Drexhage H.A. Analysis of peripheral blood lymphocyte subsets, NK cells, and delayed type hypersensitivity skin test in patients with premature ovarian failure. Am J Reprod Immunol 33 (1995) 495-502
60. Chernyshov V.P., Radysh T.V., Gura I.V., Tatarchuk T.P., and Khominskaya Z.B. Immune disorders in women with premature ovarian failure in initial period. Am J Reprod Immunol 46 (2001) 220-225
61. Conway G.S. Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol (Oxf) 45 (1996) 657-663
62. Kalantaridou S.N., Davis S.R., and Nelson L.M. Premature ovarian failure. Endocrinol Metab Clin North Am 27 (1998) 989-1006
63. Bakalov V.K., Anasti J.N., Calis K.A., Vanderhoof V.H., Premkumar A., Chen S., et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril 84 (2005) 958-965